Table 1 Characteristics of the study population.

From: Quantitative volumetric computed tomography embolic analysis, the Qanadli score, biomarkers, and clinical prognosis in patients with acute pulmonary embolism

Age (years)

66.8 (± 17.0)

Gender

Male

79 (39.3%)

Female

122 (60.7%)

History of cancer

Yes

48 (23.9%)

No

153 (76.1%)

History of chronic heart lung disease

Yes

88 (45.1%)

No

107 (54.9%)

Arrival vital signs

SpO2 (%)

93.9 (± 5.6)

SBP

128.6 (± 25.9)

DBP

73.4 (± 16.4)

RR

21.9 (± 5.24)

sPESI score

High risk (≥ 1)

142 (79.3%)

Low risk (< 1)

37 (20.7%)

Lab data

BNP

 

BNP > 400

39 (27.9%)

BNP ≤ 400

101 (72.1%)

Troponin I

Troponin I > 0.04

81 (44.8%)

Troponin I ≤ 0.04

100 (55.2%)

D-dimer

10,363 (± 74,701)

Echocardiogram data

sPAP

42.3 (± 16.8)

RV dysfunction

Yes

42 (30.2%)

No

97 (69.8%)

Mortality

30 days Mortality

17 (8.99%)

90 days Mortality

28 (14.8%)

  1. SBP systolic blood pressure, RR respiratory rate, sPAP systolic pulmonary arterial pressure, RV right ventricle, LV left ventricle, RV/LV ratio of diameter of RV and diameter of LV.
Back to article page